Launching the ImmuneWatch DETECT Early Access Program

Demo showing a terminal that runs ImmuneWatch DETECT

Are you ready to change the way you interpret your TCR sequencing data? We’re thrilled to announce the launch of our ImmuneWatch DETECT Early Access Program – a unique opportunity for innovators that are using TCR sequencing. Then this Early Access Program is a good match! Why should you work with ImmuneWatch DETECT? 👉 Stop […]

New white paper on TCR sequencing for cancer vaccine developers

To know the efficacy of your cancer vaccine, it is crucial to analyse the T cell response. Because of its versatility, TCR sequencing is a rising tool to monitor such immune responses. However, the full potential of TCR sequencing remains unrealised at present. One of the major challenges is the capability to distil the relevant […]

ImmuneWatch Validates their Expertise in TCR Specificity Prediction in an Independent Machine Learning Competition

We are excited to share our recent win in the IMMREP23 Kaggle competition focused on TCR (T-cell receptor) specificity prediction. This win is a testament to our team’s expertise in implementing advanced machine learning in immunology. The competition required predicting TCR-epitope binding, a key challenge in the field of immunoinformatics. To assess the current state-of-the-art […]

ImmuneWatch receives Horizon Europe funding in a new innovative European partnership to tackle hurdles in malaria vaccine development

With cutting-edge technologies and an unwavering commitment, the EU-funded CAPTIVATE project has the mission to create a next-generation malaria vaccine that targets multiple stages of the deadliest malaria parasite, P. falciparum. Malaria remains a significant global health issue, with approximately 247 million cases and 619,000 fatalities reported in 2021. It primarily affects the most susceptible […]

Introducing a paradigm shift in TCR-based diagnostics

Introducing a paradigm shift in TCR-based diagnostics

Each infection, vaccine, cancer cell or autoimmune disease can leave a telltale signature in your collection of T cells, the TCR repertoire. That is a consequence of how your immune system recognises and memorises intruders. We at ImmuneWatch and others firmly believe that by tapping into this immunological memory, groundbreaking new diagnostics can be developed. […]

Watch out for negative data bias in machine learning

Watch out for negative data bias in machine learning

Machine learning, with its potential to revolutionise the field of immunology, isn’t immune to the pitfalls of biased data. That is a cautious lesson discussed in a new academic publication by ImmuneWatch co-founders Prof. Kris Laukens and Prof. Pieter Meysman. In this paper, they discuss recent work by Gao et al., who sought to predict […]

Invited keynote speaker: The future of AI for health

After two years HIHR is happy to reconnect again to Flanders Bio and to organise its 12th pitch-edition in Antwerp on May 31, 2023 with Quickfire sessions scheduled the week before. The event takes place on the eve of Knowledge for Growth and they welcome you to a Room with a Zoo, located right next […]

Selected to pitch at Knowledge for Growth

We are excited that our abstract “Implementing Artificial Intelligence in the vaccine development process” has been selected for a pitch at Knowledge for Growth! During the Flanders Vaccine Elevator Pitch session we get the unique opportunity to present our company to academic researchers, entrepreneurs, TTO’s, business managers, scientific advisors and investors within the field of […]

Keynote: Next Generation Vaccines and Immunotherapy

We are happy to announce that our CTO, Pieter Meysman, has been invited as a speaker at the Cross-Regional Pitch & Match session on Next Generation Vaccines & Immunotherapy. The event is organised by Flanders Vaccine and BioWin – The Health Cluster of Wallonia and will take place on 16th of May in Leuven, Belgium […]